Business
Apollo Medical Holdings, Inc. Reports Fourth Quarter and Year-End 2021 Results
Company to Host Conference Call Today at 2 p.m. PT/5 p.m. ET ALHAMBRA, Calif., Feb. 24, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and
About this update from Astrana Health Inc.
[{"type":"text","content":"Company to Host Conference Call Today at 2 p.m. PT/5 p.m. ET\n\n\nALHAMBRA, Calif., Feb. 24, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. (\"ApolloMed,\" and together with its subsidiaries and affiliated entities, the \"Company\") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced its consolidated financial results for the fourth quarter and year ended December 31, 2021. \n\n \n \n \n \n \n \n\n \nFinancial Highlights for Fourth Quarter 2021: \nEarnings per share - diluted (\"EPS - diluted\") of $0.30 per share, an increase of 11% from $0.27 per share for the prior-year quarter Total revenue of $195.1 million, an increase of 10% from $176.8 million for the prior-year quarter Q4 net income attributable to ApolloMed of $13.8 million, an increase of 37% from $10.1 million for the prior-year quarterFinancial Highlights for the Year Ended December 31, 2021:\nEPS - diluted of $1.63 per share, an increase of 61% from $1.01 per share for the prior year Total revenue of $773.9 million, an increase of 13% from $687.2 million for the prior year Net income attributable to ApolloMed of $73.9 million, an increase of 95% from $37.9 million for the prior year Adjusted EBITDA of $174.2 million, an increase of 34% from $129.9 million for the prior year(1) Cash and cash equivalents of $233.1 million at December 31, 2021(1) See \"Reconciliation of Net Income to EBITDA and Adjusted EBITDA\" and \"Use of Non-GAAP Financial Measures\" below for additional information.\nRecent Operating Highlights: \nIn December 2021, the Company announced that its affiliate AP-AMH 2 Medical Corporation entered into a definitive agreement to acquire 100% of the fully diluted capitalization of Jade Health Care Medical Group (\"Jade Health\"), a primary and specialty care physicians' group focused on providing high-quality care to its local communities in the San Francisco Bay Area. The Company anticipates closing this transaction by the end of the second quarter of 2022 and will fund the transaction from cash on hand. In January 2022, the Company announced that it acquired 100% of the fully diluted capitalization of Orma Health, Inc., and Provider Growth Solutions, LLC (together, \"Orma Health\") in accordance with an agreement between Apol...